Once-daily insulin detemir added to oral antidiabetic drugs results in less weight gain and a trend for reduced hypoglycaemia in comparison to NPH insulin in Japanese patients with type 2 diabetes

被引：0
|
作者：
Tajima, N.
Iwamoto, Y.
Kaku, K.
Kawamori, R.
Nishida, T.
Kobayashi, M.
机构：
[1] Jikei Univ, Sch Med, Tokyo, Japan
[2] Tokyo Womens Med Univ, Dept Med, Tokyo, Japan
[3] Kawasaki Med Sch, Diabet & Emdocrine Div, Okayama, Japan
[4] Juntendo Univ, Dept Med, Tokyo, Japan
[5] Novo Nordisk Pharm Ltd, Tokyo, Japan
[6] Toyama Univ, Toyama 930, Japan
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0996
引用
收藏
页码：609 / 609
页数：1
相关论文
共 50 条
  • [41] Once-daily insulin detemir in a cohort of insulin-naive patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study
    Meneghini, L. F.
    Dornhorst, A.
    Sreenan, S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 1029 - 1035
  • [42] Comparison of two titration programmes for adding insulin detemir to oral antidiabetic drugs in patients with poorly controlled type 2 diabetes mellitus
    Liu, Sung-Chen
    Chuang, Shih-Ming
    Wang, Chao-Hung
    Chien, Ming-Nan
    Lee, Chun-Chuan
    Chen, Wei-Che
    Leung, Ching-Hsiang
    Lin, Jiun-Lu
    DIABETES OBESITY & METABOLISM, 2023, 25 (03): : 700 - 706
  • [43] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE-2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
    Buysman, E.
    Conner, C.
    Liu, F.
    Aagren, M.
    Bouchard, J.
    VALUE IN HEALTH, 2011, 14 (03) : A98 - A98
  • [44] A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir in a Pen Device or NPH Insulin in a Vial
    Buysman, Erin K.
    Conner, Christopher
    Liu, Fang
    Aagren, Mark
    Bouchard, Jonathan
    DIABETES, 2011, 60 : A628 - A628
  • [45] Switching patients with type 1 and type 2 diabetes on basal-bolus regimen from twice-daily NPH to once-daily insulin detemir leads to improved control and safety
    Aczel, Stefan
    Hansen, Jes B.
    Tsur, Anat
    DIABETES, 2007, 56 : A544 - A544
  • [46] Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and achieving glycemic control,when administered in addition to conventional oral antidiabetic therapy in the treatment of type 2 diabetes patients; A meta-analysis
    Fakhoury, W.
    Lockhart, I
    Kotchie, R.
    Le, Reun C.
    Aagren, M.
    Nielsen, S.
    VALUE IN HEALTH, 2007, 10 (06) : A256 - A256
  • [47] Treatment with insulin detemir once daily is associated with lower risk of hypoglycemia at similar levels of HbA1c compared to once-daily NPH insulin in subjects with type 1 diabetes mellitus
    Shaw, Jonathan E.
    Larsen, Jens
    Pedersen, Claus B.
    Tang-Fui, Serge
    DIABETES, 2008, 57 : A595 - A595
  • [48] Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study
    King, A. B.
    DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 69 - 71
  • [49] Observational Study of Once-Daily Insulin Detemir in People with Type 2 Diabetes Aged 75 Years or Older
    Karnieli, Eddy
    Baeres, Florian M. M.
    Dzida, Grzegorz
    Ji, Qiuhe
    Ligthelm, Robert
    Ross, Stuart
    Svendsen, Anne Louise
    Yale, Jean-Francois
    DRUGS & AGING, 2013, 30 (03) : 167 - 175
  • [50] Once-daily insulin glargine requires a significantly lower dose than insulin detemir twice daily to achieve good glycaemic control in patients with type 2 diabetes failing oral therapy
    Swinnen, S. G. H.
    Dain, M. P.
    Aronson, R.
    Roberts, D.
    Davies, M.
    Gerstein, H. C.
    Pfeiffer, A. F. H.
    DeVries, J. H.
    Hoekstra, J. B. L.
    Holleman, F.
    DIABETOLOGIA, 2009, 52 : S380 - S380
12345